Plain-English translation of NCT07492004 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study — meaning researchers are collecting biological samples and medical information from people with monogenic diabetes, which is a rare form of diabetes caused by changes in a single gene. By gathering data from many patients over time, researchers hope to better understand these genetic forms of diabetes and potentially improve how they're diagnosed and treated in the future.
Monogenic diabetes is rare and often misdiagnosed as type 1 or type 2 diabetes, which can delay proper treatment. By creating a large database of genetic information and medical histories, researchers can learn more about these conditions and help doctors identify and care for patients with genetic diabetes more effectively.
You likely qualify if…
You likely don't qualify if…
You would provide a blood or tissue sample for genetic testing and allow researchers to access your medical records and follow your health over time. The study is building a large specimen bank and database, so you may be contacted periodically to share updated information about your diabetes and overall health as the research continues.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
China
Enrollment target
~5,000 participants
Started
February 2021
Primary completion
July 2030
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ming Liu
Tianjin Medical University General Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.